Biodegradable Stents - Global Market Outlook (2016-2022)

Biodegradable Stents - Global Market Outlook (2016-2022)

  • Published: April 2017
  • ID: SMRC16416

According to Stratistics MRC, the Global Biodegradable Stents market is accounted for $0.47 billion in 2016 and is expected to reach $3.51 billion by 2022 growing at a CAGR of 39.8% during the forecast period 2016 to 2022. The prevailing usage of stents in treatment of artery disease is rapidly providing market growth. Patients demand for minimal invasive surgeries, growing geriatric population and technological advancements are some of the factors driving market. However, safety & regulatory issues and cost issues are some reasons behind the market lag.

Hospitals segment is expected to dominate the market, it is because of majority hospitals procuring medical products and consumables in bulk. Moreover, coronary artery disease is expected to dominate application segment on account of growing geriatric population and rising consequences of disease occurring. In geographical segment, North America is estimated to dominate the market due to high prevalence of cardiovascular diseases. In addition to that, Asia Pacific market is expected to grow at highest CAGR attributing to growing awareness about Bioabsorbable stents.
 
Some of the key players of the Biodegradable Stents market include Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, Arterius Limited, BIOTRONIK SE & Co. KG, Biotronik, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Meril Life Sciences, REVA Medical, Inc., SMT (Part of Sahajanand Group of Companies), Tepha, Inc. and Xenogenics Corporation.
                 
End-Users Covered:
• Cardiac Centers
• Hospitals

Applications covered:
• Coronary Artery Disease
• Peripheral Artery Disease

Materials covered:
• Metallic Stents
• Polymeric Stents

Drugs covered:
• Limus-Based Drugs
• Paclitaxel

Absorption Rates covered:
• Slow-Absorption Stents
• Fast-Absorption Stents

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of APAC
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary  
    
2 Preface 
  
 2.1 Abstract  
 2.2 Stake Holders 
 2.3 Research Scope 
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources 
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
    
3 Market Trend Analysis 
 3.1 Introduction 
 3.2 Drivers  
 3.3 Restraints 
 3.4 Opportunities 
 3.5 Threats  
 3.6 End-User Analysis 
 3.7 Application Analysis
 3.8 Emerging Markets 
 3.9 Futuristic Market Scenario
    
4 Porters Five Force Analysis 

 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry 
    
5 Global Biodegradable Stents Market, By End-User
 5.1 Introduction 
 5.2 Cardiac Centers 
 5.3 Hospitals  
    
6 Global Biodegradable Stents Market, By Application
 6.1 Introduction 
 6.2 Coronary Artery Disease
 6.3 Peripheral Artery Disease
    
7 Global Biodegradable Stents Market, By Material

 7.1 Introduction 
 7.2 Metallic Stents 
 7.3 Polymeric Stents  
    
8 Global Biodegradable Stents Market, By Drug

 8.1 Introduction 
 8.2 Limus-Based Drugs 
 8.3 Paclitaxel  
    
9 Global Biodegradable Stents Market, By Absorption Rate
 9.1 Introduction 
 9.2 Slow-Absorption Stents 
 9.3 Fast-Absorption Stents
    
10 Global Biodegradable Stents Market, By Geography
 10.1 North America 
  10.1.1 US 
  10.1.2 Canada 
  10.1.3 Mexico 
 10.2 Europe  
  10.2.1 Germany 
  10.2.2 France 
  10.2.3 Italy 
  10.2.4 UK 
  10.2.5 Spain 
  10.2.6 Rest of Europe
 10.3 Asia Pacific 
  10.3.1 Japan 
  10.3.2 China 
  10.3.3 India 
  10.3.4 Australia 
  10.3.5 New Zealand
  10.3.6 Rest of Asia Pacific
 10.4 Rest of the World 
  10.4.1 Middle East
  10.4.2 Brazil 
  10.4.3 Argentina
  10.4.4 South Africa
  10.4.5 Egypt 
    
11 Key Developments  
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers
 11.3 New Product Launch
 11.4 Expansions 
 11.5 Other Key Strategies
    
12 Company Profiling  
 12.1 Abbott Laboratories 
 12.2 Amaranth Medical, Inc.
 12.3 Arterial Remodeling Technologies SA
 12.4 Arterius Limited 
 12.5 BIOTRONIK SE & Co. KG
 12.6 Biotronik  
 12.7 Elixir Medical Corporation
 12.8 Kyoto Medical Planning Co., Ltd.
 12.9 Meril Life Sciences 
 12.10 REVA Medical, Inc. 
 12.11 SMT (Part of Sahajanand Group of Companies)
 12.12 Tepha, Inc.  
 12.13 Xenogenics Corporation


List of Tables   
1 Global Biodegradable Stents Market Outlook, By Region (2014-2022) ($MN)
2 Global Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
3 Global Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
4 Global Biodegradable Stents Market Outlook, By Hospitals  (2014-2022) ($MN)
5 Global Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
6 Global Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
7 Global Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
8 Global Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
9 Global Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
10 Global Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
11 Global Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
12 Global Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
13 Global Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
14 Global Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
15 Global Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
16 Global Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
17 North America Biodegradable Stents Market Outlook, By Country (2014-2022) ($MN)
18 North America Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
19 North America Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
20 North America Biodegradable Stents Market Outlook, By Hospitals  (2014-2022) ($MN)
21 North America Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
22 North America Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
23 North America Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
24 North America Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
25 North America Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
26 North America Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
27 North America Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
28 North America Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
29 North America Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
30 North America Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
31 North America Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
32 North America Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
33 Europe Biodegradable Stents Market Outlook, By Country (2014-2022) ($MN)
34 Europe Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
35 Europe Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
36 Europe Biodegradable Stents Market Outlook, By Hospitals  (2014-2022) ($MN)
37 Europe Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
38 Europe Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
39 Europe Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
40 Europe Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
41 Europe Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
42 Europe Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
43 Europe Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
44 Europe Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
45 Europe Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
46 Europe Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
47 Europe Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
48 Europe Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
49 Asia Pacific Biodegradable Stents Market Outlook, By Country (2014-2022) ($MN)
50 Asia Pacific Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
51 Asia Pacific Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
52 Asia Pacific Biodegradable Stents Market Outlook, By Hospitals  (2014-2022) ($MN)
53 Asia Pacific Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
54 Asia Pacific Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
55 Asia Pacific Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
56 Asia Pacific Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
57 Asia Pacific Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
58 Asia Pacific Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
59 Asia Pacific Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
60 Asia Pacific Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
61 Asia Pacific Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
62 Asia Pacific Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
63 Asia Pacific Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
64 Asia Pacific Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
65 RoW Biodegradable Stents Market Outlook, By Country (2014-2022) ($MN)
66 RoW Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
67 RoW Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
68 RoW Biodegradable Stents Market Outlook, By Hospitals  (2014-2022) ($MN)
69 RoW Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
70 RoW Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
71 RoW Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
72 RoW Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
73 RoW Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
74 RoW Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
75 RoW Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
76 RoW Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
77 RoW Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
78 RoW Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
79 RoW Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
80 RoW Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials